The bioefficacy of complexes 1 4 and 8 has been examined against the growth of bacteria in vitro to evaluate their anti-microbial potential.
The bioefficacy of the complex has been examined against the growth of bacteria in vitro to evaluate its anti-microbial potential.
The constructs were investigated in vitro to evaluate the organization and stiffness of the extracellular matrix (ECM) formed by human fetal osteoblasts (HFObs) cultured inside the microchannels.
The bioefficacy of the ligands and their complexes have been examined against the growth of bacteria and fungi in vitro to evaluate their antimicrobial potential.
Stability studies in vitro to evaluate the leakage of radioactivity, autoradiographic studies to evaluate homogeneity and shielding, as well as therapeutic efficacy in an animal model of skin cancer of the selected 32P patch were performed.
In addition, the combination of both drugs was studied in vitro to evaluate the schedule and potential synergy.
elementary bodies (EB) and human peripheral blood monocytes (PBMo) persistently infected with C. tr. in vitro to evaluate the sensitivity of different molecular biology methods and assays.
Cell invasiveness was determined in vitro to evaluate the ability of SACC-M cell to transmigrate a layer of reconstructed extracellular matrix (Matrigel).
